Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Bone Marrow Transplantation
|
September 26, 2001
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
J Blatt, S H Gold, J M Wiley, et al.
Gene Therapy
|
November 20, 2003
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
D M McCarty, H Fu, P E Monahan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 12, 2010
Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B
P E Monahan, R Liesner, S T Sullivan, et al.
Gene Therapy
|
March 18, 2011
Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy
A Keravala, C L Chavez, G Hu, et al.
Journal of Virology
|
March 23, 2000
Kinetics of recombinant adeno-associated virus-mediated gene transfer
A K Malik, P E Monahan, D L Allen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 19, 2013
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia
N Narkbunnam, J Sun, G Hu, et al.
Endocrinology
|
February 11, 1991
Augmented hypothalamic proopiomelanocortin gene expression with pubertal development in the male rat: evidence for an androgen receptor-independent action
J R Kerrigan, P M Martha, R J Krieg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 9, 2009
Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV
T Gui, A Reheman, H Ni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 10, 2014
Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement
A G Lau, J Sun, W B Hannah, et al.
Gene Therapy
|
June 24, 2011
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
C Li, N Narkbunnam, R J Samulski, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Bone Marrow Transplantation
|
September 26, 2001
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
J Blatt, S H Gold, J M Wiley, et al.
Gene Therapy
|
November 20, 2003
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
D M McCarty, H Fu, P E Monahan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 12, 2010
Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B
P E Monahan, R Liesner, S T Sullivan, et al.
Gene Therapy
|
March 18, 2011
Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy
A Keravala, C L Chavez, G Hu, et al.
Journal of Virology
|
March 23, 2000
Kinetics of recombinant adeno-associated virus-mediated gene transfer
A K Malik, P E Monahan, D L Allen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 19, 2013
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia
N Narkbunnam, J Sun, G Hu, et al.
Endocrinology
|
February 11, 1991
Augmented hypothalamic proopiomelanocortin gene expression with pubertal development in the male rat: evidence for an androgen receptor-independent action
J R Kerrigan, P M Martha, R J Krieg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 9, 2009
Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV
T Gui, A Reheman, H Ni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 10, 2014
Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement
A G Lau, J Sun, W B Hannah, et al.
Gene Therapy
|
June 24, 2011
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
C Li, N Narkbunnam, R J Samulski, et al.
Page
of 3